EUVIMEDEUVIMED entdecken
Leserbrief

Subcutaneous Immunotherapy: It Is Time for Real-World Data

Daniel Sentana-Lledo iD, Arjun Gupta iD

JCO Oncology Practice · 2026-06 · 22 (6) · 1137-1138

DOI: 10.1200/op-26-00070 ↗

Kurz gefasst

Leserbrief in der Zeitschrift JCO Oncology Practice, 2026-06. Verfasst von Daniel Sentana-Lledo und 1 weiteren Autor:innen. Beteiligte Einrichtung: Daniel Sentana-Lledo, MD, Dana-Farber Cancer Institute, Boston, MA; and Arjun Gupta, MD, City of Hope Cancer Center Phoenix, Phoenix, AZ. Die Arbeit nennt 10 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Daniel Sentana-Lledo, MD, Dana-Farber Cancer Institute, Boston, MA; and Arjun Gupta, MD, City of Hope Cancer Center Phoenix, Phoenix, AZ.

ORCID-Profile: Daniel Sentana-Lledo, Arjun Gupta

Zitieren

APA

Sentana-Lledo, D., & Gupta, A. (2026). Subcutaneous Immunotherapy: It Is Time for Real-World Data. JCO Oncology Practice, 22(6), 1137-1138. https://doi.org/10.1200/op-26-00070

Vancouver

Sentana-Lledo D, Gupta A. Subcutaneous Immunotherapy: It Is Time for Real-World Data. JCO Oncology Practice. 2026;22(6):1137-1138. doi:10.1200/op-26-00070

BibTeX
@article{SentanaLledo2026,
  author = {Sentana-Lledo, Daniel and Gupta, Arjun},
  title = {Subcutaneous Immunotherapy: It Is Time for Real-World Data},
  journal = {JCO Oncology Practice},
  year = {2026},
  volume = {22},
  number = {6},
  pages = {1137--1138},
  doi = {10.1200/op-26-00070}
}
Kostenlos starten →